Neuroscience Training Program, University of Wisconsin Madison, Madison, WI, United States.
Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, United States.
Front Immunol. 2023 Aug 17;14:1233908. doi: 10.3389/fimmu.2023.1233908. eCollection 2023.
In recent decades there has been a large focus on understanding the mechanisms of peripheral immune cell infiltration into the central nervous system (CNS) in neuroinflammatory diseases. This intense research led to several immunomodulatory therapies to attempt to regulate immune cell infiltration at the blood brain barrier (BBB), the choroid plexus (ChP) epithelium, and the glial barrier. The fate of these infiltrating immune cells depends on both the neuroinflammatory environment and their type-specific interactions with innate cells of the CNS. Although the fate of the majority of tissue infiltrating immune cells is death, a percentage of these cells could become tissue resident immune cells. Additionally, key populations of immune cells can possess the ability to "drain" out of the CNS and act as messengers reporting signals from the CNS toward peripheral lymphatics. Recent data supports that the meningeal lymphatic system is involved not just in fluid homeostatic functions in the CNS but also in facilitating immune cell migration, most notably dendritic cell migration from the CNS to the meningeal borders and to the draining cervical lymph nodes. Similar to the peripheral sites, draining immune cells from the CNS during neuroinflammation have the potential to coordinate immunity in the lymph nodes and thus influence disease. Here in this review, we will evaluate evidence of immune cell drainage from the brain via the meningeal lymphatics and establish the importance of this in animal models and humans. We will discuss how targeting immune cells at sites like the meningeal lymphatics could provide a new mechanism to better provide treatment for a variety of neurological conditions.
近几十年来,人们高度关注理解外周免疫细胞浸润神经炎症性疾病中枢神经系统(CNS)的机制。这项深入的研究催生了几种免疫调节疗法,试图调节血脑屏障(BBB)、脉络丛(ChP)上皮和神经胶质屏障处的免疫细胞浸润。这些浸润免疫细胞的命运取决于神经炎症环境及其与 CNS 固有细胞的特定类型相互作用。尽管大多数组织浸润免疫细胞的命运是死亡,但这些细胞中的一部分可成为组织驻留免疫细胞。此外,关键免疫细胞群体可具备“流出”CNS 的能力,并充当报告 CNS 向周围淋巴系统发出信号的信使。最近的数据支持脑膜淋巴管系统不仅参与 CNS 中的液体稳态功能,还参与促进免疫细胞迁移,特别是树突状细胞从 CNS 迁移到脑膜边界和引流的颈淋巴结。与外周部位类似,神经炎症期间从 CNS 引流的免疫细胞有可能协调淋巴结中的免疫,从而影响疾病。在这篇综述中,我们将评估通过脑膜淋巴管从大脑中排出免疫细胞的证据,并在动物模型和人类中确立其重要性。我们将讨论在脑膜淋巴管等部位靶向免疫细胞如何为治疗各种神经疾病提供新的机制。